Residual Expression of the Reprogramming Factors Prevents Differentiation of iPSC Generated from Human Fibroblasts and Cord Blood CD34+ Progenitors

• Verónica Ramos-Mejía ,

  * E-mail: veronica.ramos@genyo.es (VR); pablo.menendez@genyo.es (PM)

  Affiliation Centre Pfizer-Universidad de Granada-Junta de Andalucía for Genomics, Oncological Research (GENyO), Granada, Spain

  ⨯
• Rosa Montes,

  Affiliation Centre Pfizer-Universidad de Granada-Junta de Andalucía for Genomics, Oncological Research (GENyO), Granada, Spain

  ⨯
• Clara Bueno,

  Affiliation Centre Pfizer-Universidad de Granada-Junta de Andalucía for Genomics, Oncological Research (GENyO), Granada, Spain

  ⨯
• Verónica Ayllón,

  Affiliation Centre Pfizer-Universidad de Granada-Junta de Andalucía for Genomics, Oncological Research (GENyO), Granada, Spain

  ⨯
• Pedro J. Real,

  Affiliation Centre Pfizer-Universidad de Granada-Junta de Andalucía for Genomics, Oncological Research (GENyO), Granada, Spain

  ⨯
• René Rodríguez,

  Affiliation Centre Pfizer-Universidad de Granada-Junta de Andalucía for Genomics, Oncological Research (GENyO), Granada, Spain

  ⨯
• Pablo Menendez

  * E-mail: veronica.ramos@genyo.es (VR); pablo.menendez@genyo.es (PM)

  Affiliation Centre Pfizer-Universidad de Granada-Junta de Andalucía for Genomics, Oncological Research (GENyO), Granada, Spain

  ⨯